NCT00605514View on ClinicalTrials.gov

Ebola and Marburg Virus Vaccines

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 25, 2008

Primary Completion Date

June 21, 2010

Study Completion Date

June 21, 2010

Conditions
Ebola VaccinesMarburg Virus DiseaseEbola Virus DiseaseMarburgvirusEbolavirus
Interventions
DRUG

VRC-EBODNA023-00-VP

DRUG

VRC-MARDNA025-00-VP

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00605514 - Ebola and Marburg Virus Vaccines | Biotech Hunter | Biotech Hunter